remain posit long-term thesi well posit
transit value-bas care intact ep beat driven invest
incom favor current year develop posit indic cost trend
view ci transit temporari headwind believ underli growth optumrx
believ long-term thesi remain intact result noth
chang view view quarter squar in-lin expect
in-lin consensu favor prior year develop neg risk adjust true
up essenti off-set favor current year develop give us confid
medic cost contain optimist report cost trend could bode
well rest group membership track littl lighter expect
similar ci transit view temporari headwind rather indic
impact ci transit
revis lower revenu guidanc suggest us ci may transit larger
portion member onto express script platform earlier anticip recal
ci indic would fulli insourc adjust claim annual run-rate
revenu assum compani transit member year
estim approxim revenu impact optumrx assum
revenue/script earlier expect transit affect revenu model
materi affect earn estim discuss compani suggest
ci pharmaci membership low ebit contribut mechan result
bp increas optumrx oper margin project
estim ci migrat major remain live onto
assum transit next quarter expect
optumrx revenu growth like compani long-term growth rang
due transit howev strong sell season could off-set
maintain outperform rate price target
maintain outperform rate price target impli share
trade adj ep estim increas adj ep
estim approxim in-lin beat quarter rais
adjust ep estim lower revenu estim
account transit ci pharmaci membership revenu estim
incl invest incom previous estim
decreas
pleas see page report import disclosur
posit share believ compani domin market share
health plan busi first-mov advantag close integr healthcar
servic busi provid compani competit advantag rel peer
group expect continu grow least line market health plan
busi potenti exceed industri averag growth rate notabl medicar
advantag howev believ real growth stori lie within compani optum
segment optum grown aggreg oper earn
level integr uhc optum enabl compani
succeed payment model increasingli shift toward value-bas reimburs
medicar advantag enrol
repres
commerci ex-hif better
expect
medicaid ex-hif better
slower expect growth optum
unitedhealth group incorpor diversifi health well-b compani
oper two segment unitedhealthcar uhc includ unitedhealthcar
commun state unitedhealthcar intern optum includ
optumhealth optuminsight optumrx
million except per-shar data
cowen compani estim
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per-shar data
compani report cowen compani
oper loss ratio product expens oper earn tax rate tax earn attribut non-controlling incom common amort expens share outstand fulli net chang year-over-year oper incom common end decemb cowen
million except per-shar data
compani report cowen compani
oper loss ratio loss ratio product product expens oper revenue oper oper earn tax rate tax earn attribut non-controlling incom common adjust intang amort expens effect intang amort share outstand fulli net chang year-over-yearpremium revenu cowen
million
compani report cowen compani
asset receiv incom tax current equip net acquir intang asset liabilitiesmed cost payabl accru polici paper current debt less current non-controlling equitycommon stock issu paid-in comp non-controlling sharehold liab liquid ratio current sale claim payabl premium premium structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
million
compani report cowen compani
 incom tax compens chang oper item account cost payabl polici flow oper secur paid acquisit net cash equip capit common stock issuanc foreign currenc rate chang cash cash increas decreas end decemb cowen
million
compani report cowen compani
 incom tax compens chang oper item account cost payabl polici oper paid acquisit net cash equip capit invest common stock long-term proce commerci paper issuanc long-term fund financ foreign currenc rate chang cash cash increas decreas end decemb cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
becom largest employ owned/affili physician countri via
acquisit partnership optumhealth sub-seg pursu
integr care deliveri model optumhealth sub-seg includ
provid partnership ownership past align incent particularli rise
trend declin payment environ proven difficult furthermor initi
result optumcar shown promis certain market unclear whether
strategi scalabl success lower cost long term unabl
appropri align incent encourag provid take risk patient
popul compani determin strategi costli gener
suffici roi risk stuck larg number capit intens asset may
difficult divest
